Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
IDEAYA Biosciences Grants Equity Awards Under Nasdaq Rule 5635(c)(4)
If tracking equity dilution and compensation metrics, monitor the $36.74 exercise price reference point set on September 24, 2026.
Based on reporting from yahoo-tickers-tape-movers.
IDEAYA Biosciences (NASDAQ: IDYA) announced on Friday, September 25, 2026, that its Compensation Committee approved inducement stock options on September 24, 2026, featuring an exercise price of $36.74 per share. Traders tracking equity compensation events should note the four-year vesting schedule tied to these grants.
Market context for this story
As of: PremarketLoading quotes…
Informational only — not investment advice. Full markets →
$IDYA$IDYA
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/IDYA. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
IDEAYA Biosciences (NASDAQ: IDYA) reported on Friday, September 25, 2026, that its Compensation Committee approved stock option grants under Nasdaq Listing Rule 5635(c)(4) as an inducement material to new employees entering service.
### Inducement Grant Structure
The stock options carry an exercise price of $36.74 per share, matching the closing price of IDEAYA's common stock on the grant date of September 24, 2026. According to the disclosures, 25% of the options vest on the first anniversary of the commencement date, with the remaining 75% vesting in equal monthly installments over the subsequent three years.
### Money Play If evaluating equity compensation filings for $IDYA+WL, watch the $36.74 strike anchor level for potential dilution tracking and insider positioning shifts.
###
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
If tracking equity dilution and compensation metrics, monitor the $36.74
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: September 25, 2026 at 7:56 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
biotech equity dilution
A biotech company gave out stock options to new employees tied to the recent stock price. Beginners should watch these events because creating new shares can slightly dilute the value of existing shares over time.
What changed
IDEAYA Biosciences granted inducement stock options to new hires with a $36.74 exercise price.
Who wins / who loses
New employees benefit from equity upside, while existing shareholders face minor future share dilution.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $IDYAWatch — track, don’t rush
Keep an eye on the company's stock to see how new employee shares affect overall value.
View $IDYA chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Skip options for this kind of news because routine hiring grants rarely cause major sudden price moves.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Track biotech labor market trends and executive hiring announcements.
What would break this thesis
- Significant unexpected clinical trial failures or broader sector sell-offs that overshadow routine equity filings.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).